- Home
- AVBP vs ADSE Comparison
AVBP vs ADSE Comparison
Compare AVBP & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBP
- ADSE
- Stock Information
- Founded
- AVBP 2021
- ADSE 1980
- Country
- AVBP United States
- ADSE Ireland
- Employees
- AVBP N/A
- ADSE 302
- Industry
- AVBP
- ADSE Industrial Specialties
- Sector
- AVBP
- ADSE Consumer Discretionary
- Exchange
- AVBP NYSE
- ADSE Nasdaq
- Market Cap
- AVBP 705.8M
- ADSE 603.2M
- IPO Year
- AVBP 2024
- ADSE N/A
- Fundamental
- Price
- AVBP $25.22
- ADSE $12.98
- Analyst Decision
- AVBP Strong Buy
- ADSE
- Analyst Count
- AVBP 7
- ADSE 0
- Target Price
- AVBP $39.29
- ADSE N/A
- AVG Volume (30 Days)
- AVBP 377.5K
- ADSE 94.9K
- Earning Date
- AVBP 08-13-2025
- ADSE 05-12-2025
- Dividend Yield
- AVBP N/A
- ADSE N/A
- EPS Growth
- AVBP N/A
- ADSE N/A
- EPS
- AVBP N/A
- ADSE N/A
- Revenue
- AVBP N/A
- ADSE $113,896,884.00
- Revenue This Year
- AVBP $66.25
- ADSE $219.58
- Revenue Next Year
- AVBP N/A
- ADSE N/A
- P/E Ratio
- AVBP N/A
- ADSE N/A
- Revenue Growth
- AVBP N/A
- ADSE 2.45
- 52 Week Low
- AVBP $15.47
- ADSE $9.00
- 52 Week High
- AVBP $36.37
- ADSE $16.35
- Technical
- Relative Strength Index (RSI)
- AVBP 67.19
- ADSE 60.58
- Support Level
- AVBP $22.65
- ADSE $9.84
- Resistance Level
- AVBP $25.80
- ADSE $10.98
- Average True Range (ATR)
- AVBP 1.32
- ADSE 1.08
- MACD
- AVBP 0.18
- ADSE 0.32
- Stochastic Oscillator
- AVBP 87.89
- ADSE 98.03
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.